Antiproliferative activity, mechanism of action and oral antitumor activity of CP-4126, a fatty acid derivative of gemcitabine, in in vitro ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2011-06

AUTHORS

Andries M. Bergman, Auke D. Adema, Jan Balzarini, Skjalg Bruheim, Iduna Fichtner, Paul Noordhuis, Øystein Fodstad, Finn Myhren, Marit L. Sandvold, Hans R. Hendriks, Godefridus J. Peters

ABSTRACT

Gemcitabine is a deoxycytidine (dCyd) analog with activity in leukemia and solid tumors, which requires phosphorylation by deoxycytidine kinase (dCK). Decreased membrane transport is a mechanism of resistance to gemcitabine. In order to facilitate gemcitabine uptake and prolong retention in the cell, a lipophilic pro-drug was synthesized (CP-4126), with an elaidic fatty acid esterified at the 5'position. CP-4126 was tested in cell lines resistant to cytarabine, another dCyd analog or gemcitabine. Activity of gemcitabine and the derivative was comparable in the parent cell lines, while in dCK deficient cells all compounds were inactive. However, inhibition of nucleoside transport increased the IC(50) for gemcitabine up to 200-fold, but not for CP-4126, underlining the independence of a nucleoside transporter. For in vivo evaluation, nude mice bearing a human xenograft were treated intraperitoneally every third day for five doses at the maximal tolerated dose. In melanoma, sarcoma, lung, prostate, pancreatic and breast cancer xenografts, gemcitabine and CP-4126 were equally and highly effective; in four other xenografts moderately but equally active. In contrast to gemcitabine, CP-4126 could be administered orally, with a schedule and dose dependent toxicity and antitumor activity. In a colon cancer xenograft, antitumor activity of orally administered CP-4126 was equal to the intraperitoneally administered drug. In conclusion, CP-4126 is membrane transporter independent. Intraperitoneally administered CP-4126 was as effective as gemcitabine in several xenografts and CP-4126 is tolerated when orally administered. CP-4126 seems to be a promising new anticancer drug. More... »

PAGES

456-466

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s10637-009-9377-7

DOI

http://dx.doi.org/10.1007/s10637-009-9377-7

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1002295981

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/20066470


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1115", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Pharmacology and Pharmaceutical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Administration, Oral", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Biological Availability", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Death", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Line, Tumor", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Proliferation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cytidine Deaminase", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Deoxycytidine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Disease Models, Animal", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dogs", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Fatty Acids", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Nucleoside Deaminases", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Xenograft Model Antitumor Assays", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "VU University Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.16872.3a", 
          "name": [
            "Department of Medical Oncology, VU University Medical Center, P.O. Box 7057, 1007 MB Amsterdam, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bergman", 
        "givenName": "Andries M.", 
        "id": "sg:person.01123611451.07", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01123611451.07"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "VU University Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.16872.3a", 
          "name": [
            "Department of Medical Oncology, VU University Medical Center, P.O. Box 7057, 1007 MB Amsterdam, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Adema", 
        "givenName": "Auke D.", 
        "id": "sg:person.01174106546.49", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01174106546.49"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "KU Leuven", 
          "id": "https://www.grid.ac/institutes/grid.5596.f", 
          "name": [
            "Rega Institute for Medical Research, Katholieke Universiteit Leuven, Leuven, Belgium"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Balzarini", 
        "givenName": "Jan", 
        "id": "sg:person.0636572314.12", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0636572314.12"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Radium Hospital, Oslo, Norway"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bruheim", 
        "givenName": "Skjalg", 
        "id": "sg:person.0733325533.91", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0733325533.91"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Max Delbr\u00fcck Center for Molecular Medicine", 
          "id": "https://www.grid.ac/institutes/grid.419491.0", 
          "name": [
            "Max-Delbr\u00fcck-Center for Molecular Medicine, Berlin-Buch, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fichtner", 
        "givenName": "Iduna", 
        "id": "sg:person.0777701322.49", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0777701322.49"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "VU University Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.16872.3a", 
          "name": [
            "Department of Medical Oncology, VU University Medical Center, P.O. Box 7057, 1007 MB Amsterdam, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Noordhuis", 
        "givenName": "Paul", 
        "id": "sg:person.01171546142.92", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01171546142.92"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Radium Hospital, Oslo, Norway"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fodstad", 
        "givenName": "\u00d8ystein", 
        "id": "sg:person.0615562340.45", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0615562340.45"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Aqualis (Norway)", 
          "id": "https://www.grid.ac/institutes/grid.488248.a", 
          "name": [
            "Clavis Pharma, Oslo, Norway"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Myhren", 
        "givenName": "Finn", 
        "id": "sg:person.01233354003.94", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01233354003.94"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Aqualis (Norway)", 
          "id": "https://www.grid.ac/institutes/grid.488248.a", 
          "name": [
            "Clavis Pharma, Oslo, Norway"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sandvold", 
        "givenName": "Marit L.", 
        "id": "sg:person.01301467203.23", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01301467203.23"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Hendriks Pharmaceutical Consulting, Purmerend, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hendriks", 
        "givenName": "Hans R.", 
        "id": "sg:person.01300125274.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01300125274.36"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "VU University Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.16872.3a", 
          "name": [
            "Department of Medical Oncology, VU University Medical Center, P.O. Box 7057, 1007 MB Amsterdam, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Peters", 
        "givenName": "Godefridus J.", 
        "id": "sg:person.01255301342.17", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01255301342.17"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1128/aac.35.3.410", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001346302"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0006-2952(93)90566-f", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002109082"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0006-2952(93)90566-f", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002109082"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/0008-5472.can-05-4203", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002208104"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.10753", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004861017"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1023/a:1010679411001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011527518", 
          "https://doi.org/10.1023/a:1010679411001"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.bcp.2003.09.028", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015174107"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0006-2952(98)00318-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018647627"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s002800050492", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020415290", 
          "https://doi.org/10.1007/s002800050492"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1053/j.gastro.2008.09.067", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023922931"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-04-1497", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024091404"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ijc.2910540316", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025059979"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0168-3659(01)00470-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025566145"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2141.2008.07467.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026913418"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1634/theoncologist.13-s1-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034893823"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/0008-5472.can-05-0989", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036701449"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/15257770802145819", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037122275"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0145-2126(83)90005-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037530825"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0277-5379(91)90142-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038362006"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0006-2952(86)90160-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039199247"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0006-2952(86)90160-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039199247"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0304-4157(96)00008-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039231663"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1368-7646(02)00002-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039632637"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0959-8049(93)90048-k", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040154074"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/ppo.0b013e318074e6c3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040802695"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/ppo.0b013e318074e6c3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040802695"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejca.2003.10.011", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041619937"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/15257770600890269", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041856409"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0006-2952(93)90444-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043896140"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0006-2952(93)90444-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043896140"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0006-2952(94)90207-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044669039"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0006-2952(94)90207-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044669039"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ijc.20835", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045263532"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6602673", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049622684", 
          "https://doi.org/10.1038/sj.bjc.6602673"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6602673", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049622684", 
          "https://doi.org/10.1038/sj.bjc.6602673"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/02841860802183620", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050421913"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrc1951", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053488336", 
          "https://doi.org/10.1038/nrc1951"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrc1951", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053488336", 
          "https://doi.org/10.1038/nrc1951"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jnci/82.13.1107", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1059815881"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jnci/83.11.757", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1059816512"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074482011", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1078668363", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1079645709", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1079715430", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1081992355", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082124357", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082618932", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1083111451", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1083327366", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2011-06", 
    "datePublishedReg": "2011-06-01", 
    "description": "Gemcitabine is a deoxycytidine (dCyd) analog with activity in leukemia and solid tumors, which requires phosphorylation by deoxycytidine kinase (dCK). Decreased membrane transport is a mechanism of resistance to gemcitabine. In order to facilitate gemcitabine uptake and prolong retention in the cell, a lipophilic pro-drug was synthesized (CP-4126), with an elaidic fatty acid esterified at the 5'position. CP-4126 was tested in cell lines resistant to cytarabine, another dCyd analog or gemcitabine. Activity of gemcitabine and the derivative was comparable in the parent cell lines, while in dCK deficient cells all compounds were inactive. However, inhibition of nucleoside transport increased the IC(50) for gemcitabine up to 200-fold, but not for CP-4126, underlining the independence of a nucleoside transporter. For in vivo evaluation, nude mice bearing a human xenograft were treated intraperitoneally every third day for five doses at the maximal tolerated dose. In melanoma, sarcoma, lung, prostate, pancreatic and breast cancer xenografts, gemcitabine and CP-4126 were equally and highly effective; in four other xenografts moderately but equally active. In contrast to gemcitabine, CP-4126 could be administered orally, with a schedule and dose dependent toxicity and antitumor activity. In a colon cancer xenograft, antitumor activity of orally administered CP-4126 was equal to the intraperitoneally administered drug. In conclusion, CP-4126 is membrane transporter independent. Intraperitoneally administered CP-4126 was as effective as gemcitabine in several xenografts and CP-4126 is tolerated when orally administered. CP-4126 seems to be a promising new anticancer drug.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s10637-009-9377-7", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1094201", 
        "issn": [
          "0167-6997", 
          "1573-0646"
        ], 
        "name": "Investigational New Drugs", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "3", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "29"
      }
    ], 
    "name": "Antiproliferative activity, mechanism of action and oral antitumor activity of CP-4126, a fatty acid derivative of gemcitabine, in in vitro and in vivo tumor models", 
    "pagination": "456-466", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "0aee7ba39763b9fb7e4a42db102de0de17db90d9c3e7e19f091ef6fb84cc9c7c"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "20066470"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "8309330"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s10637-009-9377-7"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1002295981"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s10637-009-9377-7", 
      "https://app.dimensions.ai/details/publication/pub.1002295981"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T13:24", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8659_00000545.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3076580/"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s10637-009-9377-7'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s10637-009-9377-7'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s10637-009-9377-7'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s10637-009-9377-7'


 

This table displays all metadata directly associated to this object as RDF triples.

343 TRIPLES      21 PREDICATES      88 URIs      38 LITERALS      26 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s10637-009-9377-7 schema:about N003efbc516094722919bd027154a94a4
2 N17a5d9d02aed410b8beafa142af592e8
3 N17d9f9fbbf834d6a953be0c1ee5205c5
4 N31c9ed03e722452184add7efc513dd01
5 N69aeb38a589c46cab113099ef3a86d0f
6 N6bb4855ef818466b8c21431e5613f8d9
7 N6ddf3c8d0f094de78975825ab21bb1a9
8 N6f4ed6d8f1154269a4944361d22e1124
9 N902a2e7aa7b2434d8d0fd77722b84ac3
10 N9d513fa307e4404ab58564d1d71464e5
11 Na3ad6884805e4cf2859259c8d45b8878
12 Nabc1d4990bab4e72913df83840cfcaba
13 Ncce89bd27e1f46f18eb2239e4366620b
14 Ndcc4035a4c4242e5ba61dd21f3ab18c5
15 Ne2326fc220f9455f9be02c32ef5d23d2
16 Nf3b365dc233f42a1b543b195e7097a66
17 Nf918af39795049f08f663729c65f2eaf
18 anzsrc-for:11
19 anzsrc-for:1115
20 schema:author Naed98b1fcbeb49d481c667898000bc4e
21 schema:citation sg:pub.10.1007/s002800050492
22 sg:pub.10.1023/a:1010679411001
23 sg:pub.10.1038/nrc1951
24 sg:pub.10.1038/sj.bjc.6602673
25 https://app.dimensions.ai/details/publication/pub.1074482011
26 https://app.dimensions.ai/details/publication/pub.1078668363
27 https://app.dimensions.ai/details/publication/pub.1079645709
28 https://app.dimensions.ai/details/publication/pub.1079715430
29 https://app.dimensions.ai/details/publication/pub.1081992355
30 https://app.dimensions.ai/details/publication/pub.1082124357
31 https://app.dimensions.ai/details/publication/pub.1082618932
32 https://app.dimensions.ai/details/publication/pub.1083111451
33 https://app.dimensions.ai/details/publication/pub.1083327366
34 https://doi.org/10.1002/cncr.10753
35 https://doi.org/10.1002/ijc.20835
36 https://doi.org/10.1002/ijc.2910540316
37 https://doi.org/10.1016/0006-2952(86)90160-7
38 https://doi.org/10.1016/0006-2952(93)90444-2
39 https://doi.org/10.1016/0006-2952(93)90566-f
40 https://doi.org/10.1016/0006-2952(94)90207-0
41 https://doi.org/10.1016/0145-2126(83)90005-x
42 https://doi.org/10.1016/0277-5379(91)90142-z
43 https://doi.org/10.1016/0959-8049(93)90048-k
44 https://doi.org/10.1016/j.bcp.2003.09.028
45 https://doi.org/10.1016/j.ejca.2003.10.011
46 https://doi.org/10.1016/s0006-2952(98)00318-9
47 https://doi.org/10.1016/s0168-3659(01)00470-9
48 https://doi.org/10.1016/s0304-4157(96)00008-1
49 https://doi.org/10.1016/s1368-7646(02)00002-x
50 https://doi.org/10.1053/j.gastro.2008.09.067
51 https://doi.org/10.1080/02841860802183620
52 https://doi.org/10.1080/15257770600890269
53 https://doi.org/10.1080/15257770802145819
54 https://doi.org/10.1093/jnci/82.13.1107
55 https://doi.org/10.1093/jnci/83.11.757
56 https://doi.org/10.1097/ppo.0b013e318074e6c3
57 https://doi.org/10.1111/j.1365-2141.2008.07467.x
58 https://doi.org/10.1128/aac.35.3.410
59 https://doi.org/10.1158/0008-5472.can-05-0989
60 https://doi.org/10.1158/0008-5472.can-05-4203
61 https://doi.org/10.1158/1078-0432.ccr-04-1497
62 https://doi.org/10.1634/theoncologist.13-s1-5
63 schema:datePublished 2011-06
64 schema:datePublishedReg 2011-06-01
65 schema:description Gemcitabine is a deoxycytidine (dCyd) analog with activity in leukemia and solid tumors, which requires phosphorylation by deoxycytidine kinase (dCK). Decreased membrane transport is a mechanism of resistance to gemcitabine. In order to facilitate gemcitabine uptake and prolong retention in the cell, a lipophilic pro-drug was synthesized (CP-4126), with an elaidic fatty acid esterified at the 5'position. CP-4126 was tested in cell lines resistant to cytarabine, another dCyd analog or gemcitabine. Activity of gemcitabine and the derivative was comparable in the parent cell lines, while in dCK deficient cells all compounds were inactive. However, inhibition of nucleoside transport increased the IC(50) for gemcitabine up to 200-fold, but not for CP-4126, underlining the independence of a nucleoside transporter. For in vivo evaluation, nude mice bearing a human xenograft were treated intraperitoneally every third day for five doses at the maximal tolerated dose. In melanoma, sarcoma, lung, prostate, pancreatic and breast cancer xenografts, gemcitabine and CP-4126 were equally and highly effective; in four other xenografts moderately but equally active. In contrast to gemcitabine, CP-4126 could be administered orally, with a schedule and dose dependent toxicity and antitumor activity. In a colon cancer xenograft, antitumor activity of orally administered CP-4126 was equal to the intraperitoneally administered drug. In conclusion, CP-4126 is membrane transporter independent. Intraperitoneally administered CP-4126 was as effective as gemcitabine in several xenografts and CP-4126 is tolerated when orally administered. CP-4126 seems to be a promising new anticancer drug.
66 schema:genre research_article
67 schema:inLanguage en
68 schema:isAccessibleForFree true
69 schema:isPartOf Na6327b207e6245fcaa0f861470ae3b42
70 Nf422225144d743bba28bbd0ccb4894af
71 sg:journal.1094201
72 schema:name Antiproliferative activity, mechanism of action and oral antitumor activity of CP-4126, a fatty acid derivative of gemcitabine, in in vitro and in vivo tumor models
73 schema:pagination 456-466
74 schema:productId N3ab105bb900245c3a0429d86c59c6096
75 N9592a33d29b54712bbc2a85edc7f6b23
76 Nb11da37956684fb1a9f1542dd8d0f1c0
77 Ne859f4485d7642398b21c75d78840304
78 Nfc22aa1561d44981ac5bb52be74d2151
79 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002295981
80 https://doi.org/10.1007/s10637-009-9377-7
81 schema:sdDatePublished 2019-04-10T13:24
82 schema:sdLicense https://scigraph.springernature.com/explorer/license/
83 schema:sdPublisher N1b97743461f4468382cefce0435cbd76
84 schema:url http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3076580/
85 sgo:license sg:explorer/license/
86 sgo:sdDataset articles
87 rdf:type schema:ScholarlyArticle
88 N003efbc516094722919bd027154a94a4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
89 schema:name Deoxycytidine
90 rdf:type schema:DefinedTerm
91 N033a8e2da83147a79fe0a70cced9f283 rdf:first sg:person.01255301342.17
92 rdf:rest rdf:nil
93 N17a5d9d02aed410b8beafa142af592e8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
94 schema:name Cytidine Deaminase
95 rdf:type schema:DefinedTerm
96 N17d9f9fbbf834d6a953be0c1ee5205c5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
97 schema:name Animals
98 rdf:type schema:DefinedTerm
99 N1b97743461f4468382cefce0435cbd76 schema:name Springer Nature - SN SciGraph project
100 rdf:type schema:Organization
101 N31c9ed03e722452184add7efc513dd01 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
102 schema:name Administration, Oral
103 rdf:type schema:DefinedTerm
104 N3ab105bb900245c3a0429d86c59c6096 schema:name nlm_unique_id
105 schema:value 8309330
106 rdf:type schema:PropertyValue
107 N5f66ffbbe1714a029707a627f631855c rdf:first sg:person.01301467203.23
108 rdf:rest Ndd4c2c6d9ef04075bf9c7f7e26de7976
109 N69aeb38a589c46cab113099ef3a86d0f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Cell Proliferation
111 rdf:type schema:DefinedTerm
112 N69b495df6c1f413985c08d5065c39680 rdf:first sg:person.01174106546.49
113 rdf:rest Ne4b997a33ed442e3bb80ae3a38025890
114 N6bb4855ef818466b8c21431e5613f8d9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Disease Models, Animal
116 rdf:type schema:DefinedTerm
117 N6ddf3c8d0f094de78975825ab21bb1a9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Humans
119 rdf:type schema:DefinedTerm
120 N6f4ed6d8f1154269a4944361d22e1124 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Biological Availability
122 rdf:type schema:DefinedTerm
123 N70c3c75b32b3425c9b7f670a8315928c schema:name Hendriks Pharmaceutical Consulting, Purmerend, The Netherlands
124 rdf:type schema:Organization
125 N832c235f965845f59773957d72f33200 schema:name Radium Hospital, Oslo, Norway
126 rdf:type schema:Organization
127 N902a2e7aa7b2434d8d0fd77722b84ac3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Fatty Acids
129 rdf:type schema:DefinedTerm
130 N916ed499a2d44e52b594e50be26a5f2c rdf:first sg:person.01171546142.92
131 rdf:rest N9caa92d279c04237a001f170d77ab288
132 N9592a33d29b54712bbc2a85edc7f6b23 schema:name doi
133 schema:value 10.1007/s10637-009-9377-7
134 rdf:type schema:PropertyValue
135 N9caa92d279c04237a001f170d77ab288 rdf:first sg:person.0615562340.45
136 rdf:rest Ne923595cae1542f5818022ab660d5888
137 N9d513fa307e4404ab58564d1d71464e5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Cell Line, Tumor
139 rdf:type schema:DefinedTerm
140 Na0a8d9d26aea4d919f0c0f07c057f932 schema:name Radium Hospital, Oslo, Norway
141 rdf:type schema:Organization
142 Na3ad6884805e4cf2859259c8d45b8878 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Cell Death
144 rdf:type schema:DefinedTerm
145 Na6327b207e6245fcaa0f861470ae3b42 schema:volumeNumber 29
146 rdf:type schema:PublicationVolume
147 Nabc1d4990bab4e72913df83840cfcaba schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Nucleoside Deaminases
149 rdf:type schema:DefinedTerm
150 Naed98b1fcbeb49d481c667898000bc4e rdf:first sg:person.01123611451.07
151 rdf:rest N69b495df6c1f413985c08d5065c39680
152 Nb11da37956684fb1a9f1542dd8d0f1c0 schema:name readcube_id
153 schema:value 0aee7ba39763b9fb7e4a42db102de0de17db90d9c3e7e19f091ef6fb84cc9c7c
154 rdf:type schema:PropertyValue
155 Ncce89bd27e1f46f18eb2239e4366620b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Antineoplastic Agents
157 rdf:type schema:DefinedTerm
158 Ndcc4035a4c4242e5ba61dd21f3ab18c5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
159 schema:name Mice
160 rdf:type schema:DefinedTerm
161 Ndd4c2c6d9ef04075bf9c7f7e26de7976 rdf:first sg:person.01300125274.36
162 rdf:rest N033a8e2da83147a79fe0a70cced9f283
163 Ne2326fc220f9455f9be02c32ef5d23d2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
164 schema:name Xenograft Model Antitumor Assays
165 rdf:type schema:DefinedTerm
166 Ne4b997a33ed442e3bb80ae3a38025890 rdf:first sg:person.0636572314.12
167 rdf:rest Nf3f53284372e4693aad1d9c71e7720c2
168 Ne859f4485d7642398b21c75d78840304 schema:name pubmed_id
169 schema:value 20066470
170 rdf:type schema:PropertyValue
171 Ne923595cae1542f5818022ab660d5888 rdf:first sg:person.01233354003.94
172 rdf:rest N5f66ffbbe1714a029707a627f631855c
173 Nf3b365dc233f42a1b543b195e7097a66 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
174 schema:name Dogs
175 rdf:type schema:DefinedTerm
176 Nf3f53284372e4693aad1d9c71e7720c2 rdf:first sg:person.0733325533.91
177 rdf:rest Nf90e4825084343a4ae58502f729b36f9
178 Nf422225144d743bba28bbd0ccb4894af schema:issueNumber 3
179 rdf:type schema:PublicationIssue
180 Nf90e4825084343a4ae58502f729b36f9 rdf:first sg:person.0777701322.49
181 rdf:rest N916ed499a2d44e52b594e50be26a5f2c
182 Nf918af39795049f08f663729c65f2eaf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
183 schema:name Treatment Outcome
184 rdf:type schema:DefinedTerm
185 Nfc22aa1561d44981ac5bb52be74d2151 schema:name dimensions_id
186 schema:value pub.1002295981
187 rdf:type schema:PropertyValue
188 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
189 schema:name Medical and Health Sciences
190 rdf:type schema:DefinedTerm
191 anzsrc-for:1115 schema:inDefinedTermSet anzsrc-for:
192 schema:name Pharmacology and Pharmaceutical Sciences
193 rdf:type schema:DefinedTerm
194 sg:journal.1094201 schema:issn 0167-6997
195 1573-0646
196 schema:name Investigational New Drugs
197 rdf:type schema:Periodical
198 sg:person.01123611451.07 schema:affiliation https://www.grid.ac/institutes/grid.16872.3a
199 schema:familyName Bergman
200 schema:givenName Andries M.
201 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01123611451.07
202 rdf:type schema:Person
203 sg:person.01171546142.92 schema:affiliation https://www.grid.ac/institutes/grid.16872.3a
204 schema:familyName Noordhuis
205 schema:givenName Paul
206 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01171546142.92
207 rdf:type schema:Person
208 sg:person.01174106546.49 schema:affiliation https://www.grid.ac/institutes/grid.16872.3a
209 schema:familyName Adema
210 schema:givenName Auke D.
211 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01174106546.49
212 rdf:type schema:Person
213 sg:person.01233354003.94 schema:affiliation https://www.grid.ac/institutes/grid.488248.a
214 schema:familyName Myhren
215 schema:givenName Finn
216 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01233354003.94
217 rdf:type schema:Person
218 sg:person.01255301342.17 schema:affiliation https://www.grid.ac/institutes/grid.16872.3a
219 schema:familyName Peters
220 schema:givenName Godefridus J.
221 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01255301342.17
222 rdf:type schema:Person
223 sg:person.01300125274.36 schema:affiliation N70c3c75b32b3425c9b7f670a8315928c
224 schema:familyName Hendriks
225 schema:givenName Hans R.
226 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01300125274.36
227 rdf:type schema:Person
228 sg:person.01301467203.23 schema:affiliation https://www.grid.ac/institutes/grid.488248.a
229 schema:familyName Sandvold
230 schema:givenName Marit L.
231 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01301467203.23
232 rdf:type schema:Person
233 sg:person.0615562340.45 schema:affiliation Na0a8d9d26aea4d919f0c0f07c057f932
234 schema:familyName Fodstad
235 schema:givenName Øystein
236 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0615562340.45
237 rdf:type schema:Person
238 sg:person.0636572314.12 schema:affiliation https://www.grid.ac/institutes/grid.5596.f
239 schema:familyName Balzarini
240 schema:givenName Jan
241 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0636572314.12
242 rdf:type schema:Person
243 sg:person.0733325533.91 schema:affiliation N832c235f965845f59773957d72f33200
244 schema:familyName Bruheim
245 schema:givenName Skjalg
246 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0733325533.91
247 rdf:type schema:Person
248 sg:person.0777701322.49 schema:affiliation https://www.grid.ac/institutes/grid.419491.0
249 schema:familyName Fichtner
250 schema:givenName Iduna
251 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0777701322.49
252 rdf:type schema:Person
253 sg:pub.10.1007/s002800050492 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020415290
254 https://doi.org/10.1007/s002800050492
255 rdf:type schema:CreativeWork
256 sg:pub.10.1023/a:1010679411001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011527518
257 https://doi.org/10.1023/a:1010679411001
258 rdf:type schema:CreativeWork
259 sg:pub.10.1038/nrc1951 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053488336
260 https://doi.org/10.1038/nrc1951
261 rdf:type schema:CreativeWork
262 sg:pub.10.1038/sj.bjc.6602673 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049622684
263 https://doi.org/10.1038/sj.bjc.6602673
264 rdf:type schema:CreativeWork
265 https://app.dimensions.ai/details/publication/pub.1074482011 schema:CreativeWork
266 https://app.dimensions.ai/details/publication/pub.1078668363 schema:CreativeWork
267 https://app.dimensions.ai/details/publication/pub.1079645709 schema:CreativeWork
268 https://app.dimensions.ai/details/publication/pub.1079715430 schema:CreativeWork
269 https://app.dimensions.ai/details/publication/pub.1081992355 schema:CreativeWork
270 https://app.dimensions.ai/details/publication/pub.1082124357 schema:CreativeWork
271 https://app.dimensions.ai/details/publication/pub.1082618932 schema:CreativeWork
272 https://app.dimensions.ai/details/publication/pub.1083111451 schema:CreativeWork
273 https://app.dimensions.ai/details/publication/pub.1083327366 schema:CreativeWork
274 https://doi.org/10.1002/cncr.10753 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004861017
275 rdf:type schema:CreativeWork
276 https://doi.org/10.1002/ijc.20835 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045263532
277 rdf:type schema:CreativeWork
278 https://doi.org/10.1002/ijc.2910540316 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025059979
279 rdf:type schema:CreativeWork
280 https://doi.org/10.1016/0006-2952(86)90160-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039199247
281 rdf:type schema:CreativeWork
282 https://doi.org/10.1016/0006-2952(93)90444-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043896140
283 rdf:type schema:CreativeWork
284 https://doi.org/10.1016/0006-2952(93)90566-f schema:sameAs https://app.dimensions.ai/details/publication/pub.1002109082
285 rdf:type schema:CreativeWork
286 https://doi.org/10.1016/0006-2952(94)90207-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044669039
287 rdf:type schema:CreativeWork
288 https://doi.org/10.1016/0145-2126(83)90005-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1037530825
289 rdf:type schema:CreativeWork
290 https://doi.org/10.1016/0277-5379(91)90142-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1038362006
291 rdf:type schema:CreativeWork
292 https://doi.org/10.1016/0959-8049(93)90048-k schema:sameAs https://app.dimensions.ai/details/publication/pub.1040154074
293 rdf:type schema:CreativeWork
294 https://doi.org/10.1016/j.bcp.2003.09.028 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015174107
295 rdf:type schema:CreativeWork
296 https://doi.org/10.1016/j.ejca.2003.10.011 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041619937
297 rdf:type schema:CreativeWork
298 https://doi.org/10.1016/s0006-2952(98)00318-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018647627
299 rdf:type schema:CreativeWork
300 https://doi.org/10.1016/s0168-3659(01)00470-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025566145
301 rdf:type schema:CreativeWork
302 https://doi.org/10.1016/s0304-4157(96)00008-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039231663
303 rdf:type schema:CreativeWork
304 https://doi.org/10.1016/s1368-7646(02)00002-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1039632637
305 rdf:type schema:CreativeWork
306 https://doi.org/10.1053/j.gastro.2008.09.067 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023922931
307 rdf:type schema:CreativeWork
308 https://doi.org/10.1080/02841860802183620 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050421913
309 rdf:type schema:CreativeWork
310 https://doi.org/10.1080/15257770600890269 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041856409
311 rdf:type schema:CreativeWork
312 https://doi.org/10.1080/15257770802145819 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037122275
313 rdf:type schema:CreativeWork
314 https://doi.org/10.1093/jnci/82.13.1107 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059815881
315 rdf:type schema:CreativeWork
316 https://doi.org/10.1093/jnci/83.11.757 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059816512
317 rdf:type schema:CreativeWork
318 https://doi.org/10.1097/ppo.0b013e318074e6c3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040802695
319 rdf:type schema:CreativeWork
320 https://doi.org/10.1111/j.1365-2141.2008.07467.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1026913418
321 rdf:type schema:CreativeWork
322 https://doi.org/10.1128/aac.35.3.410 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001346302
323 rdf:type schema:CreativeWork
324 https://doi.org/10.1158/0008-5472.can-05-0989 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036701449
325 rdf:type schema:CreativeWork
326 https://doi.org/10.1158/0008-5472.can-05-4203 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002208104
327 rdf:type schema:CreativeWork
328 https://doi.org/10.1158/1078-0432.ccr-04-1497 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024091404
329 rdf:type schema:CreativeWork
330 https://doi.org/10.1634/theoncologist.13-s1-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034893823
331 rdf:type schema:CreativeWork
332 https://www.grid.ac/institutes/grid.16872.3a schema:alternateName VU University Medical Center
333 schema:name Department of Medical Oncology, VU University Medical Center, P.O. Box 7057, 1007 MB Amsterdam, The Netherlands
334 rdf:type schema:Organization
335 https://www.grid.ac/institutes/grid.419491.0 schema:alternateName Max Delbrück Center for Molecular Medicine
336 schema:name Max-Delbrück-Center for Molecular Medicine, Berlin-Buch, Germany
337 rdf:type schema:Organization
338 https://www.grid.ac/institutes/grid.488248.a schema:alternateName Aqualis (Norway)
339 schema:name Clavis Pharma, Oslo, Norway
340 rdf:type schema:Organization
341 https://www.grid.ac/institutes/grid.5596.f schema:alternateName KU Leuven
342 schema:name Rega Institute for Medical Research, Katholieke Universiteit Leuven, Leuven, Belgium
343 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...